244 related articles for article (PubMed ID: 36864473)
1. Factors associated with the composition of the gut microbiome in patients with established rheumatoid arthritis and its value for predicting treatment responses.
Koh JH; Lee EH; Cha KH; Pan CH; Kim D; Kim WU
Arthritis Res Ther; 2023 Mar; 25(1):32. PubMed ID: 36864473
[TBL] [Abstract][Full Text] [Related]
2. The changes of intestinal flora and its relevance with memory Tfh and B cells in rheumatoid arthritis patients treated with csDMARDs and csDMARDs + bDMARDs.
Jiang C; Chi S; Wang F; Zhao C; Yang X; Liu M; Ma B; Chen J; Su C; Duan X
Immunobiology; 2024 May; 229(3):152798. PubMed ID: 38537424
[TBL] [Abstract][Full Text] [Related]
3. Advances in the implications of the gut microbiota on the treatment efficacy of disease-modifying anti-rheumatic drugs in rheumatoid arthritis.
Fan J; Jiang T; He D
Front Immunol; 2023; 14():1189036. PubMed ID: 37841256
[TBL] [Abstract][Full Text] [Related]
4. Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort.
Lukas C; Mary J; Debandt M; Daïen C; Morel J; Cantagrel A; Fautrel B; Combe B
Arthritis Res Ther; 2019 Nov; 21(1):243. PubMed ID: 31730497
[TBL] [Abstract][Full Text] [Related]
5. Serum Levels of IFABP2 and Differences in
Zaragoza-García O; Castro-Alarcón N; Pérez-Rubio G; Falfán-Valencia R; Briceño O; Navarro-Zarza JE; Parra-Rojas I; Tello M; Guzmán-Guzmán IP
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768285
[TBL] [Abstract][Full Text] [Related]
6. DMARDs-Gut Microbiota Feedback: Implications in the Response to Therapy.
Zaragoza-García O; Castro-Alarcón N; Pérez-Rubio G; Guzmán-Guzmán IP
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33114390
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Gut Microbiota in Rheumatoid Arthritis Patients: Disease-Related Dysbiosis and Modifications Induced by Etanercept.
Picchianti-Diamanti A; Panebianco C; Salemi S; Sorgi ML; Di Rosa R; Tropea A; Sgrulletti M; Salerno G; Terracciano F; D'Amelio R; Laganà B; Pazienza V
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30261687
[TBL] [Abstract][Full Text] [Related]
8. Comparative Analysis of Fecal Microbiota Composition Between Rheumatoid Arthritis and Osteoarthritis Patients.
Lee JY; Mannaa M; Kim Y; Kim J; Kim GT; Seo YS
Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31557878
[TBL] [Abstract][Full Text] [Related]
9. The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New-Onset Rheumatoid Arthritis.
Artacho A; Isaac S; Nayak R; Flor-Duro A; Alexander M; Koo I; Manasson J; Smith PB; Rosenthal P; Homsi Y; Gulko P; Pons J; Puchades-Carrasco L; Izmirly P; Patterson A; Abramson SB; Pineda-Lucena A; Turnbaugh PJ; Ubeda C; Scher JU
Arthritis Rheumatol; 2021 Jun; 73(6):931-942. PubMed ID: 33314800
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate promotes recovery of arthritis-induced alveolar bone loss and modifies the composition of the oral-gut microbiota.
de Arruda JAA; Corrêa JD; Singh Y; Oliveira SR; Machado CC; Schneider AH; Medeiros JD; Fernandes GR; Macari S; Barrioni BR; Santos MS; Duffles LF; Nakaya HTI; Fukada SY; Graves DT; Cunha FQ; Silva TA
Anaerobe; 2022 Jun; 75():102577. PubMed ID: 35490916
[TBL] [Abstract][Full Text] [Related]
11. Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis.
Gupta VK; Cunningham KY; Hur B; Bakshi U; Huang H; Warrington KJ; Taneja V; Myasoedova E; Davis JM; Sung J
Genome Med; 2021 Sep; 13(1):149. PubMed ID: 34517888
[TBL] [Abstract][Full Text] [Related]
12. Influence of proton pump inhibitor or rebamipide use on gut microbiota of rheumatoid arthritis patients.
Kim JW; Jeong Y; Park SJ; Jin H; Lee J; Ju JH; Ji GE; Park SH
Rheumatology (Oxford); 2021 Feb; 60(2):708-716. PubMed ID: 32789440
[TBL] [Abstract][Full Text] [Related]
13. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis.
Chen J; Wright K; Davis JM; Jeraldo P; Marietta EV; Murray J; Nelson H; Matteson EL; Taneja V
Genome Med; 2016 Apr; 8(1):43. PubMed ID: 27102666
[TBL] [Abstract][Full Text] [Related]
14. S-Propargyl-Cysteine Remodels the Gut Microbiota to Alleviate Rheumatoid Arthritis by Regulating Bile Acid Metabolism.
Wang Z; Yu Y; Liao J; Hu W; Bian X; Wu J; Zhu YZ
Front Cell Infect Microbiol; 2021; 11():670593. PubMed ID: 34422677
[TBL] [Abstract][Full Text] [Related]
15. The association between increased body mass index and response to conventional synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: results from the METEOR database.
Dey M; Zhao SS; Moots RJ; Bergstra SA; Landewe RB; Goodson NJ
Rheumatology (Oxford); 2022 Feb; 61(2):713-722. PubMed ID: 33930113
[TBL] [Abstract][Full Text] [Related]
16. Alteration of Gut Microbiota in Individuals at High-Risk for Rheumatoid Arthritis Associated With Disturbed Metabolome and the Initiation of Arthritis Through the Triggering of Mucosal Immunity Imbalance.
Luo Y; Tong Y; Wu L; Niu H; Li Y; Su LC; Wu Y; Bozec A; Zaiss MM; Qing P; Zhao H; Tan C; Zhang Q; Zhao Y; Tang H; Liu Y
Arthritis Rheumatol; 2023 Oct; 75(10):1736-1748. PubMed ID: 37219936
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of serum soluble ICAM-1 and CXCL13 in the therapeutic response to TNF inhibitor in rheumatoid arthritis patients who are refractory to csDMARDs.
Zhao J; Ye X; Zhang Z
Clin Rheumatol; 2020 Sep; 39(9):2573-2581. PubMed ID: 32206975
[TBL] [Abstract][Full Text] [Related]
18. Treatment strategies are more important than drugs in the management of rheumatoid arthritis.
Drosos AA; Pelechas E; Voulgari PV
Clin Rheumatol; 2020 Apr; 39(4):1363-1368. PubMed ID: 32088801
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protocol for a pragmatic trial.
van der Leeuw MS; Welsing PMJ; de Hair MJH; Jacobs JWG; Marijnissen ACA; Linn-Rasker SP; Fodili F; Bos R; Tekstra J; van Laar JM
Trials; 2020 Apr; 21(1):313. PubMed ID: 32248829
[TBL] [Abstract][Full Text] [Related]
20. Perturbations of the gut microbiome in anti-CCP positive individuals at risk of developing rheumatoid arthritis.
Rooney CM; Mankia K; Mitra S; Moura IB; Emery P; Wilcox MH
Rheumatology (Oxford); 2021 Jul; 60(7):3380-3387. PubMed ID: 33313854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
